or Try an Advanced Search...

    Precision Medicine Stocks List

    Symbol Grade Name % Change
    RPTX F Repare Therapeutics Inc. 5.28
    NTLA F Intellia Therapeutics, Inc. 5.11
    RLAY F Relay Therapeutics, Inc. -0.75
    IDYA F IDEAYA Biosciences, Inc. 4.31
    BIOR F Biora Therapeutics, Inc. -1.23
    INMB F INmune Bio Inc. 5.37
    ORIC F Oric Pharmaceuticals, Inc. 3.09
    POAI D Predictive Oncology Inc. 3.89
    CRSP D CRISPR Therapeutics AG -2.40
    EXAI D Exscientia Limited 0.00
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
    Related Stock Lists: Biotechnology Biology CRISPR Drug Discovery Genetics Medicine Synthetic Lethality Systems Biology Advanced Solid Tumors Amyloid Amyloidosis Antitrypsin Deficiency Biomarkers Cancer Cancer Therapies Cas9 Cell Product Chimeric Antigen Receptor Chimeric Antigen Receptor T Cell Clinical Medicine

    Related ETFs - A few ETFs which own one or more of the above listed Precision Medicine stocks.

    Symbol Grade Name Weight
    ARKG F ARK Genomic Revolution Multi-Sector ETF 10.83
    CANC D Tema Oncology ETF 5.13
    GNOM F Global X Genomics & Biotechnology ETF 4.66
    ARKK B ARK Innovation ETF 4.63
    HTEC C Robo Global Healthcare Technology and Innovation ETF 3.8
    View all Precision Medicine ETFs...
    Compare ETFs
    Compare ARKK to HTEC Compare CANC to ARKK Compare CANC to GNOM

        Precision Medicine Stocks Recent News

        Date Stock Title
        Nov 21 CRSP CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)
        Nov 20 RLAY Down -27.93% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround
        Nov 20 CRSP CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell?
        Nov 20 EXAI Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
        Nov 20 CRSP CRISPR Therapeutics AG (CRSP): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 RLAY Down -23.95% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround
        Nov 19 NTLA Intellia Therapeutics Announces Promising CRISPR Therapy Results
        Nov 19 NTLA ReCode to secure funds for cystic fibrosis gene correction treatments
        Nov 19 NTLA Intellia Therapeutics price target lowered to $70 from $80 at Wells Fargo
        Nov 19 NTLA Intellia Therapeutics' Gene Therapies Fall Short Of Breakthroughs (Rating Downgrade)
        Nov 18 NTLA Intellia’s gene editing therapy shows early potential in rare heart condition
        Nov 18 CRSP CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest
        Nov 18 NTLA CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest
        Nov 18 IDYA IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
        Nov 17 CRSP CRISPR Therapeutics AG (CRSP): Among ARK Invest’s Top Stock Picks for 2024
        Nov 16 NTLA Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis
        Nov 16 CRSP 2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
        Nov 15 CRSP CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)
        Nov 15 IDYA Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
        Nov 15 POAI Predictive Oncology Third Quarter 2024 Earnings: Misses Expectations
        Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
        Related Stock Lists: Cancer Medicine Biology Biopharmaceutical Biotechnology Disease Oncology Artificial Intelligence Biomarkers Cancer Treatment Clinical Medicine Evidence Based Medicine Genomics Immune System Immunotherapy Solid Tumors Systems Biology Targeted Therapy Acid Antineoplastic Drugs
        Precision Medicine

        Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient, instead of a one‐drug‐fits‐all model. In precision medicine, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics.

        More about Precision Medicine
        Browse All Tags